Market Overview

UPDATE: Goldman Sachs Upgrades Vitamin Shoppe to Buy on Valuation, Secular Growth Outlook

Share:
Related VSI
Barclays Shrugs At Food & Staples Sector, Interest Piqued By Just 3 Names
Vitamin Shoppe Beats Sales Estimates, Misses Earnings

Goldman Sachs upgraded Vitamin Shoppe (NYSE: VSI) from Neutral to Buy and raised the price target to $65.00.

Goldman Sachs noted, "Like many growth names in our coverage, VSI has experienced multiple compression of late. We still like the supplement sector's secular growth. Moreover, we like VSI's incremental pursuit of own-brand product and international expansion, which we think brings it marginally closer to GNC's more lucrative operating model. VSI now trades near longrun relative P/E troughs, presenting us with an opportunity to buy into growth at a relative discount."

Vitamin Shoppe closed at $50.62 on Monday.

Latest Ratings for VSI

DateFirmActionFromTo
Sep 2016BarclaysInitiates Coverage onEqual-weight
Apr 2016WedbushInitiates Coverage onOutperform
Apr 2016BarclaysTerminatesEqual-weightEqual-weight

View More Analyst Ratings for VSI
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Analyst Ratings

 

Related Articles (VSI)

View Comments and Join the Discussion!